Today's Veterinary Practice

TVP_JUL-AUG2018

Today's Veterinary Practice provides comprehensive information to keep every small animal practitioner up to date on companion animal medicine and surgery as well as practice building and management.

Issue link: https://todaysveterinarypractice.epubxp.com/i/997103

Contents of this Issue

Navigation

Page 12 of 87

IMPORTANT SAFETY INFORMATION Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. Prior to administration of Interceptor Plus (milbemycin oxime/praziquantel), dogs should be tested for existing heartworm infections. The safety of Interceptor Plus has not been evaluated in dogs used for breeding or in lactating females. The following adverse reactions have been reported in dogs after administration of milbemycin oxime or praziquantel: vomiting, diarrhea, depression/lethargy, ataxia, weight loss, convulsions, weakness, and salivation. For product information, including complete safety information, please see page XX. CHOOSE THE CHEW WITH MORE GET BROAD-SPECTRUM PROTECTION WITH MORE COVERAGE THAN HEARTGARD ® PLUS FOR MORE INFORMATION, VISIT INTERCEPTORPLUS.COM. Not actual size 1 Dirofi laria immitis 2 Ancylostoma caninum 3 Ancylostoma caninum, Uncinaria stenocephala, Ancylostoma braziliense 4 Toxocara canis, Toxascaris leonina 5 Trichuris vulpis 6 Taenia pisiformis, Echinococcus multilocularis, Echinococcus granulosus, Dipylidium caninum Heartgard ® Plus (ivermectin/pyrantel) Interceptor ® Plus (milbemycin oxime/praziquantel) Heartworm disease ✓ ✓ 1 1 Hookworm ✓ ✓ 2 3 Roundworm ✓ ✓ 4 4 Whipworm ✓ 5 Tapeworm ✓ 6 Heartgard is a registered trademark of Merial. Interceptor, Elanco and the diagonal bar logo are trademarks of Elanco or its affi liates. © 2018 Elanco or its affi liates.USCACINP00292 12.

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Practice - TVP_JUL-AUG2018